ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Pearl Celebrates a Banner Year of Groundbreaking Achievements in Dental AI

Global Expansion, Key Patents, and Industry Partnerships Propel Pearl into a Transformative 2024

Pearl, the global leader in dental AI solutions, is carrying significant momentum into the new year following massive expansion and key successes in 2023, including key patent additions, new global market expansions, major industry partnerships, numerous technology awards, leadership additions and revenue growth exceeding 500%.

“Last year, Pearl made tremendous progress toward our goal of transforming dentistry and the dental health of patients around the world with AI,” said Ophir Tanz, founder and CEO of Pearl. “We will accelerate that progress and drive even greater innovation in 2024, thanks not only to our relentless innovation of best-in-class dental AI solutions for the global dental market, but also to committed partnerships with technology and institutional leaders who share our AI-powered vision for the future of dentistry.”

Pearl’s most notable 2023 milestones include:

  • New Patents: Pearl cemented the innovation at the core of its technology with a new industry patent for its chairside AI disease detection software, the second patent for its breakthrough Second Opinion® technology. The patent grants Pearl the exclusive rights to the technology system supporting the software’s application programming interface (API). Pearl was also issued a patent granting exclusive rights to the computer vision and analytics system at the core of its pioneering clinical performance software, Practice Intelligence®, bringing the company’s total number of U.S. patents to 12.
  • Global Expansion: Pearl further solidified its position at the forefront of the dental AI revolution with numerous additional global regulatory authorizations in 2023, including clearances in Israel, Turkey, Saudi Arabia, Chile, Argentina and Switzerland. Second Opinion® also became the first-and-only AI-based dental pathology detection software to gain Class IIa medical device certification under the updated European Union Medical Device Regulation (EU-MDR), one of the world's most robust health tech regulations. At the 2023 International Dental Show in Cologne, Germany, Pearl announced plans to expand access to its Practice Intelligence® solution for the European market.
  • Strategic Partnerships: Throughout 2023, Pearl announced over a dozen new partnerships, including many that bring Pearl’s clinical AI capabilities to dentistry’s leading software platforms from Patterson Dental, Planmeca, Planet DDS, CareStack, Curve, Oryx, Dentulu, VisiQuick and Vyne Dental.
  • Awards and Recognition: Pearl took home three prestigious industry awards recognizing the company’s commitment to technological excellence in both the U.S. and UK dental markets, including a 2023 Cellerant Best of Class Technology Award for the second consecutive year, two UK Dental Industry Awards for “High Technology Launch of the Year” and “New Product/Service of the Year,” and a Nifty Award for “Favorite Dental AI Company.”

To continue driving the company’s mission, Pearl also announced the expansion of its leadership team in November 2023 with the appointment of Ben Plomion as Chief Operating Officer and Mike Barniv, DDS as Vice President of Clinical Affairs.

About Pearl

Pearl is leading the global dental AI revolution with groundbreaking computer vision solutions that elevate efficiency, accuracy, and the standard of care in dentistry. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. To request a demo, please visit hellopearl.com/demo.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.